Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Tax Provisions: 2020-2025

Historic Tax Provisions for Puma Biotechnology (PBYI) over the last 5 years, with Sep 2025 value amounting to $399,000.

  • Puma Biotechnology's Tax Provisions rose 37.11% to $399,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 29.12%. This contributed to the annual value of $897,000 for FY2024, which is 17.17% down from last year.
  • Puma Biotechnology's Tax Provisions amounted to $399,000 in Q3 2025, which was up 28.71% from $310,000 recorded in Q2 2025.
  • Over the past 5 years, Puma Biotechnology's Tax Provisions peaked at $536,000 during Q4 2023, and registered a low of $8,000 during Q4 2024.
  • Moreover, its 3-year median value for Tax Provisions was $291,000 (2024), whereas its average is $271,091.
  • Its Tax Provisions has fluctuated over the past 5 years, first surged by 297.30% in 2023, then slumped by 98.51% in 2024.
  • Puma Biotechnology's Tax Provisions (Quarterly) stood at $212,000 in 2021, then soared by 38.68% to $294,000 in 2022, then surged by 82.31% to $536,000 in 2023, then plummeted by 98.51% to $8,000 in 2024, then surged by 37.11% to $399,000 in 2025.
  • Its Tax Provisions was $399,000 in Q3 2025, compared to $310,000 in Q2 2025 and $293,000 in Q1 2025.